Santseharay Ramírez

2.6k total citations · 1 hit paper
60 papers, 1.7k citations indexed

About

Santseharay Ramírez is a scholar working on Hepatology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Santseharay Ramírez has authored 60 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Hepatology, 31 papers in Epidemiology and 27 papers in Infectious Diseases. Recurrent topics in Santseharay Ramírez's work include Hepatitis C virus research (36 papers), Hepatitis B Virus Studies (28 papers) and SARS-CoV-2 and COVID-19 Research (20 papers). Santseharay Ramírez is often cited by papers focused on Hepatitis C virus research (36 papers), Hepatitis B Virus Studies (28 papers) and SARS-CoV-2 and COVID-19 Research (20 papers). Santseharay Ramírez collaborates with scholars based in Denmark, Spain and United States. Santseharay Ramírez's co-authors include Jens Bukh, Judith M. Gottwein, Yi‐Ping Li, Lotte S. Mikkelsen, Ulrik Fahnøe, Sanne B. Jensen, Long V. Pham, Xavier Forns, Sofía Pérez‐del‐Pulgar and Troels K. H. Scheel and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Gastroenterology and PLoS ONE.

In The Last Decade

Santseharay Ramírez

56 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Nirmatrelvir-resistant SARS-CoV-2 variants with high fitness in an infectious cell culture system

2022 132 citations Yuyong Zhou, Karen Anbro Gammeltoft et al. Science Advances profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Santseharay Ramírez Denmark	25	1.0k	960	545	224	209	60	1.7k
Shinya Maekawa Japan	28	1.2k 1.1×	950 1.0×	257 0.5×	666 3.0×	136 0.7×	116	2.7k
Masaya Sugiyama Japan	33	2.2k 2.1×	2.5k 2.6×	450 0.8×	631 2.8×	68 0.3×	163	3.7k
Shufeng Liu United States	22	417 0.4×	611 0.6×	541 1.0×	365 1.6×	105 0.5×	62	1.8k
Eisuke Murakami Japan	25	1.3k 1.3×	1.1k 1.1×	658 1.2×	459 2.0×	60 0.3×	102	2.1k
Tsuyoshi Adachi Japan	12	694 0.7×	406 0.4×	305 0.6×	370 1.7×	176 0.8×	20	1.2k
Judith M. Gottwein Denmark	33	2.6k 2.5×	2.4k 2.4×	712 1.3×	441 2.0×	726 3.5×	75	3.4k
Jacques Friborg United States	22	326 0.3×	882 0.9×	763 1.4×	330 1.5×	63 0.3×	41	2.1k
Artur Kaul Germany	21	2.0k 2.0×	1.7k 1.7×	566 1.0×	744 3.3×	315 1.5×	35	3.0k
Véronique Descamps France	20	916 0.9×	761 0.8×	181 0.3×	254 1.1×	230 1.1×	35	1.5k
Inge Vliegen Belgium	19	408 0.4×	592 0.6×	278 0.5×	341 1.5×	28 0.1×	33	1.4k

Countries citing papers authored by Santseharay Ramírez

Since Specialization

Citations

This map shows the geographic impact of Santseharay Ramírez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Santseharay Ramírez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Santseharay Ramírez more than expected).

Fields of papers citing papers by Santseharay Ramírez

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Santseharay Ramírez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Santseharay Ramírez. The network helps show where Santseharay Ramírez may publish in the future.

Co-authorship network of co-authors of Santseharay Ramírez

This figure shows the co-authorship network connecting the top 25 collaborators of Santseharay Ramírez. A scholar is included among the top collaborators of Santseharay Ramírez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Santseharay Ramírez. Santseharay Ramírez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fernandez-Antunez, Carlota, Line A. Ryberg, Kuan Wang, et al.. (2025). SARS-CoV-2 Remdesivir Exposure Leads to Different Evolutionary Pathways That Converge in Moderate Levels of Drug Resistance. Viruses. 17(8). 1055–1055.

Walker, Melanie R., Alexander P. Underwood, Maria Rosaria Bassi, et al.. (2024). Broadly potent spike-specific human monoclonal antibodies inhibit SARS-CoV-2 Omicron sub-lineages. Communications Biology. 7(1). 1239–1239. 1 indexed citations

Ramírez, Santseharay, et al.. (2024). Study of Scientific Production on Stress at Work in Organizations. Indian Journal of Information Sources and Services. 14(4). 136–140. 1 indexed citations

Underwood, Alexander P., Alekxander Binderup, Carlota Fernandez-Antunez, et al.. (2024). Neutralizing antibody and CD8+ T cell responses following BA.4/5 bivalent COVID-19 booster vaccination in adults with and without prior exposure to SARS-CoV-2. Frontiers in Immunology. 15. 1353353–1353353. 7 indexed citations

Christensen, Dennis, Charlotta Polacek, Daniel J. Sheward, et al.. (2023). SARS-CoV-2 spike HexaPro formulated in aluminium hydroxide and administered in an accelerated vaccination schedule partially protects Syrian Hamsters against viral challenge despite low neutralizing antibody responses. Frontiers in Immunology. 14. 941281–941281. 5 indexed citations

Fossat, Nicolas, Rui Costa, Louise Nielsen, et al.. (2023). Identification of the viral and cellular microRNA interactomes during SARS-CoV-2 infection. Cell Reports. 42(4). 112282–112282. 10 indexed citations

Zhou, Yuyong, Karen Anbro Gammeltoft, Line A. Ryberg, et al.. (2022). Nirmatrelvir-resistant SARS-CoV-2 variants with high fitness in an infectious cell culture system. Science Advances. 8(51). eadd7197–eadd7197. 132 indexed citations breakdown →

Fahnøe, Ulrik, Long V. Pham, Carlota Fernandez-Antunez, et al.. (2022). Versatile SARS-CoV-2 Reverse-Genetics Systems for the Study of Antiviral Resistance and Replication. Viruses. 14(2). 172–172. 24 indexed citations

Zhou, Yuyong, Karen Anbro Gammeltoft, Andrea Galli, et al.. (2021). Efficacy of Ion-Channel Inhibitors Amantadine, Memantine and Rimantadine for the Treatment of SARS-CoV-2 In Vitro. Viruses. 13(10). 2082–2082. 24 indexed citations

10.

Ramírez, Santseharay, Carlota Fernandez-Antunez, Andrea Galli, et al.. (2021). Overcoming Culture Restriction for SARS-CoV-2 in Human Cells Facilitates the Screening of Compounds Inhibiting Viral Replication. Antimicrobial Agents and Chemotherapy. 65(7). e0009721–e0009721. 63 indexed citations

11.

Gammeltoft, Karen Anbro, Yuyong Zhou, Andrea Galli, et al.. (2021). Hepatitis C Virus Protease Inhibitors Show Differential Efficacy and Interactions with Remdesivir for Treatment of SARS-CoV-2 In Vitro. Antimicrobial Agents and Chemotherapy. 65(9). e0268020–e0268020. 37 indexed citations

12.

Galli, Andrea, Santseharay Ramírez, & Jens Bukh. (2021). Lipid Droplets Accumulation during Hepatitis C Virus Infection in Cell-Culture Varies among Genotype 1–3 Strains and Does Not Correlate with Virus Replication. Viruses. 13(3). 389–389. 9 indexed citations

13.

Chen, Shu‐Cheng, et al.. (2020). Insights into the unique characteristics of hepatitis C virus genotype 3 revealed by development of a robust sub-genomic DBN3a replicon. Journal of General Virology. 101(11). 1182–1190. 5 indexed citations

14.

Fahnøe, Ulrik, Andrea Galli, Santseharay Ramírez, et al.. (2020). Mutations Identified in the Hepatitis C Virus (HCV) Polymerase of Patients with Chronic HCV Treated with Ribavirin Cause Resistance and Affect Viral Replication Fidelity. Antimicrobial Agents and Chemotherapy. 64(12). 8 indexed citations

15.

Galli, Andrea, et al.. (2019). Ribavirin inhibition of cell-culture infectious hepatitis C genotype 1-3 viruses is strain-dependent. Virology. 540. 132–140. 8 indexed citations

16.

Pham, Long V., Sanne B. Jensen, Ulrik Fahnøe, et al.. (2018). HCV genotype 1-6 NS3 residue 80 substitutions impact protease inhibitor activity and promote viral escape. Journal of Hepatology. 70(3). 388–397. 32 indexed citations

17.

Humes, Daryl, Santseharay Ramírez, Tanja B. Jensen, et al.. (2018). Recombinant hepatitis C virus genotype 5a infectious cell culture systems expressing minimal JFH1 NS5B sequences permit polymerase inhibitor studies. Virology. 522. 177–192. 3 indexed citations

18.

Li, Yi‐Ping, Santseharay Ramírez, Judith M. Gottwein, & Jens Bukh. (2011). Non-genotype-specific role of the hepatitis C virus 5′ untranslated region in virus production and in inhibition by interferon. Virology. 421(2). 222–234. 18 indexed citations

19.

Ramírez, Santseharay, Sofía Pérez‐del‐Pulgar, J.A. Carrión, et al.. (2009). Hepatitis C Virus Compartmentalization and Infection Recurrence after Liver Transplantation. American Journal of Transplantation. 9(7). 1591–1601. 42 indexed citations

20.

Massaguer, Anna, Santseharay Ramírez, J.A. Carrión, et al.. (2007). Evolution of the NS3 and NS5B Regions of the Hepatitis C Virus During Disease Recurrence After Liver Transplantation. American Journal of Transplantation. 7(9). 2172–2179. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact